Literature DB >> 7550728

Transformation of Brucella species with suicide and broad host-range plasmids.

J R McQuiston1, G G Schurig, N Sriranganathan, S M Boyle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7550728     DOI： 10.1385/0-89603-310-4:143

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  16 in total

1.  Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression.

Authors:  Parthiban Rajasekaran; Mohamed N Seleem; Andrea Contreras; Endang Purwantini; Gerhardt G Schurig; Nammalwar Sriranganathan; Stephen M Boyle
Journal:  Appl Environ Microbiol       Date:  2008-10-03       Impact factor: 4.792

2.  Characterization and protective property of Brucella abortus cydC and looP mutants.

Authors:  Quang Lam Truong; Youngjae Cho; Abhijit Kashinath Barate; Suk Kim; Tae-Wook Hahn
Journal:  Clin Vaccine Immunol       Date:  2014-09-24

3.  Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.

Authors:  R Vemulapalli; S Cravero; C L Calvert; T E Toth; N Sriranganathan; S M Boyle; O L Rossetti; G G Schurig
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Establishment of a gene expression system in Ochrobactrum anthropi.

Authors:  Mohamed N Seleem; Mohammed Ali; Stephen M Boyle; Biswarup Mukhopadhyay; Sharon G Witonsky; Gerhardt G Schurig; Nammalwar Sriranganathan
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

5.  Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.

Authors:  R Vemulapalli; Y He; L S Buccolo; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses.

Authors:  R Vemulapalli; Y He; S M Boyle; N Sriranganathan; G G Schurig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of Brucella abortus strain RB51.

Authors:  R Vemulapalli; Y He; S Cravero; N Sriranganathan; S M Boyle; G G Schurig
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

8.  Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.

Authors:  Yongqun He; Ramesh Vemulapalli; Gerhardt G Schurig
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

9.  Carboxyl-terminal protease regulates Brucella suis morphology in culture and persistence in macrophages and mice.

Authors:  Aloka B Bandara; Nammalwar Sriranganathan; Gerhardt G Schurig; Stephen M Boyle
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

10.  Cloning and sequencing of yajC and secD homologs of Brucella abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51.

Authors:  R Vemulapalli; A J Duncan; S M Boyle; N Sriranganathan; T E Toth; G G Schurig
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.